ONL Therapeutics’ Post

Excited to share highlights from yesterday's presentation by our co-founder and Chief Scientific Officer David Zacks at the OSN New York and Retina Meetings. As part of the Ocular Surgery News Disruptive Innovations Symposium, Dr. Zacks presented "ONL1204 Ophthalmic Solution: A Novel Approach for the Treatment of Geographic Atrophy," showcasing our unique and differentiated mechanism of action of Fas inhibition. Thank you to everyone who attended and engaged in the discussion! #OSNNYandRetina #RetinaInnovation #ONLTherapeutics #Neuroprotection #ONL1204

  • No alternative text description for this image
  • No alternative text description for this image

Thanks for participating and sharing your insight!

Melanie Fortin, MS

Ophthalmology Research Professional 👁 Clinical Operations Consultant 👁 Clinical Project Manager (CPM) 👁 Biotech and Life Sciences 👁 USAF Veteran

1w

Way to go Dr. David Zacks and ONL Therapeutics !! 👁️

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics